DALLAS, PHOENIX, and THE WOODLANDS, Texas, Initial results from an ongoing clinical trial, the first designed to examine the utility of whole-genome sequencing for triple negative breast cancer, were reported today during the CRTC-AACR San Antonio Breast Cancer Symposium. The results indicate activation of targets not previously associated with triple negative disease and could point […]
San Francisco, CA, Real Time Genomics, Inc., today announced that the Livestock Improvement Corporation (LIC) of New Zealand has signed a multi-year agreement to license RTG Investigator sequence analysis software for trait discovery in bovine genomes. Through an Early Access Program (EAP) relationship with LIC, Real Time Genomics extended its Bayesian variant analysis software to […]
NEW YORK, Levi & Korsinsky is investigating potential claims on behalf of purchasers of the securities of Pacific Biosciences of California, Inc. concerning possible violations of federal securities laws. The investigation stems from allegations that the Company failed to disclose the following: (a) that contrary to the Company’s claim that the RS system its used […]
NEW YORK, Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Pacific Biosciences of California, Inc. (“PacBio” or the “Company”) (Nasdaq: PACB – News). The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) contrary to the Company’s […]
ST. LOUIS, Cofactor Genomics, a leading biotechnology company, announced today it will release a product to allow researchers to selectively enrich, sequence, analyze and detect variants in coding and regulatory regions of the Bovine (cow) genome. The creation of a Bos taurus exome capture product will provide sequence-verified SNP’s, insertions, and deletions, without any prior […]
Findings Show the Newest Bioruptor(R) Obtains Unbiased Shearing of DNA for Next-Gen Sequencing Applications on the Illumina GAIIx Analyzer LIEGE, BELGIUM–Diagenode SA (a privately-held Belgium based company) announced that it has finished a Next-Gen Sequencing application study with the GIGA center, University of Liège (Belgium). The study highlighted the newest Bioruptor® NGS machine designed specifically […]
LEXINGTON, Mass. – RainDance Technologies, Inc., the Digital Biology™ Company, today announced that the British Columbia Cancer Agency has purchased the company’s new ThunderStorm™ System. RainDance’s ThunderStorm System is a fully-automated and walkaway high-throughput targeted sequencing solution that enables researchers to process up to 96 samples per run on a proven platform that generates higher-quality […]
VICTORIA, British Columbia Canada – GenoLogics today announced that EdgeBio, a leading sequencing services provider, has deployed the GenoLogics Laboratory Information Management System (LIMS), bringing an unprecedented level of flexibility and adaptability to its next-generation sequencing (NGS) core laboratory. The GenoLogics LIMS replaces EdgeBios existing commercial LIMS software. “We required a LIMS that was built […]
Melbourne, Australia and Menlo Park, CA, USA: Millennium Science, a life science distributor specialising in high-technology research solutions throughout Australia and New Zealand, and Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced today that they have entered an agreement to appoint Millennium Science as Pacific Biosciences’ sole distributor in Australia and New Zealand for PacBio’s breakthrough […]
Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Expressionist 7.0 for Genomic Profiling, which will be featured at the 3rd Annual Next Generation Sequencing Congress. The Congress showcases besides next generation sequencing (NGS) platforms and technologies some of the industry-leading computational tools for analyzing NGS […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
